SS-31

Research-centric overview

Peptide

Summary not yet generated. The Librarian will pick this up on the next daily run (12:00 UTC).

Community effect votes, structured logs, and side-effect summaries.

No effect profile data seeded yet for this peptide.

Effect scores blend an AI baseline with community votes. Open the full chart to see sliders and vote on each category.

Research log summary heatmap

Compact view of how logs describe shifts in pain, sleep, and performance (−5 to +5). Treat this as qualitative, anonymous signal only.

No community research logs yet. When structured logs are added, this panel will summarize typical shifts in pain, sleep, and performance.

Anonymous side-effect patterns

Rough heatmap of anonymous side-effect and positive-signal tags — a "most-mentioned" snapshot, not safety or efficacy advice.

No anonymous side-effect reports yet. When reports are submitted, this panel will show a simple heatmap of tags like "nausea", "flushing", "improved healing", and more.

Research footprint

Last analyzed Apr 17, 2026

Studies indexed

Human

Animal

AI analyzed

Evidence mix0% human · 0% animal · 0% cellular · 0% review

Highest phase: Preclinical onlyYears covered: —

Research & intelligence feed

Studies, clinical trials, community discussions, and news.

A Pilot Investigator Initiated Study to Evaluate the Safety, Tolerability and Efficacy of Elamipretide in the Treatment of Advanced Symptoms of Friedreich Ataxia (FRDA)Clinical TrialClinicalTrials.govApr 16, 2026

This study evaluated the safety, tolerability, and efficacy of Elamipretide (SS-31) in patients with advanced symptoms of Friedreich Ataxia (FRDA). The specific dose and duration of treatment were not reported in the abstract. The findings regarding efficacy and safety outcomes were not detailed.

Phase: PHASE1, PHASE2Status: COMPLETED

Evaluation of the Regeneration Capacity of Satellite Cells From the Quadriceps Compared to That of the DiaphragmClinical TrialClinicalTrials.govApr 16, 2026

This study evaluated the regeneration capacity of satellite cells from the quadriceps compared to that of the diaphragm. The specific doses and methodologies used were not detailed in the abstract. The findings may provide insights into muscle regeneration mechanisms.

Phase: NAStatus: COMPLETED

Semantic Scholar search for SS-31StudySemanticScholarDec 12, 2025

Targeted Delivery of AGO-2 to Myocardial Mitochondria via Functionalized Nanoparticles Attenuates Oxidative Stress in Diabetic Cardiomyopathy.StudyPubMedDec 12, 2025

ACS applied materials & interfaces · 2025

NNT inhibits microglial activation via mitochondrial oxidative stress in spinal cord injury.StudyPubMedDec 12, 2025

Neuroscience letters · 2025

Targeted nanoliposomal nutrient delivery for human health.StudyPubMedDec 12, 2025

World journal of gastrointestinal pharmacology and therapeutics · 2025

External databases

Helpful external resources for additional structural, pharmacologic, and literature context. These are third-party databases; always cross-check details with primary research.

Community notes

No comments yet. Share research notes, citations, or observations below.

Community research logs (detail)

No community research logs yet. Use the “Contribute data” button above to share an anonymized summary of your experience.

Anonymous side-effect reporting (detail)

This section describes how anonymous side-effect reports are aggregated into the heatmap above. Reports are anonymous and unverified, and should be read alongside primary safety data.

Use the "Report side effects" button to open a focused popup form. Please keep descriptions neutral and avoid medical language; think in terms of "nausea", "flushing", "vivid dreams", etc.